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ABSTRACT Contraction of skeletal muscle is regulated by calcium at the level of the thin filament via troponin and
tropomyosin. Studies have indicated that strong cross-bridge binding is also involved in activation of the thin filament. To
further test this, myofibrils were incubated with a wide range of fluorescent myosin subfragment 1(fS1) at pCa 9 or pCa 4 with
or without ADP. Sarcomere fluorescence intensity and the fluorescence intensity ratio (non-overlap region/overlap region)
were measured to determine the amount and location of bound fS1 in the myofibril. There was lower sarcomere fluorescence
intensity with ADP compared to without ADP for both calcium levels. Similar data were obtained from biochemical measures
of bound fS1, validating the fluorescence microscopy measurements. The intensity ratio, which is related to activation of the
thin filament, increased with increasing [fS1] with or without ADP. At pCa 9, the fluorescence intensity ratio was constant until
80–160 nM fS1 without ADP conditions, then it went up dramatically and finally attained saturation. The dramatic shift of the
ratio demonstrated the cooperative character of strong cross-bridge binding, and this was not observed at high calcium. A
similar pattern was observed with ADP in that the ratio was right-shifted with respect to total [fS1]. Saturation was obtained
with both the fluorescence intensity and ratio data. Plots of intensity ratio as a function of normalized sarcomere intensity
(bound fS1) showed little difference between with and without ADP. This suggests that the amount of strongly bound fS1, not
fS1 state (with or without ADP) is related to activation of the thin filament.
INTRODUCTION
Regulation of contraction in striated muscle involves cal-
cium binding to troponin followed by changes in the actin-
tropomyosin interaction, allowing for actomyosin interac-
tions and contraction. The steric-hindrance model was
proposed to explain the molecular mechanisms of activa-
tion. It proposes that calcium binding to troponin moves
tropomyosin to a position that does not block the interaction
of actin and myosin (reviewed in Squire and Morris, 1998).
While the early x-ray diffraction studies that gave rise to
this hypothesis were highly model-dependent, more recent
studies using electron micrographic methods generally sup-
port a model based upon tropomyosin movement (Lehman
et al., 1994; Vibert et al., 1997; Xu et al., 1999). Biochem-
ical studies show calcium-dependent changes between tro-
ponin I and actin (Tao et al., 1990; Miki and Iio, 1993) but
not tropomyosin and actin (Tao et al., 1983; Miki et al.,
1998). Conformation changes in tropomyosin at the tropo-
nin binding site are not sensitive to calcium binding (Ishii
and Lehrer, 1990), while changes outside the troponin bind-
ing region are calcium-sensitive (Farah and Reinach, 1999).
An alternative model (reviewed in Chalovich, 1992) has
been proposed for the regulation of contraction based upon
biochemical (Chalovich and Eisenberg, 1982) and mechan-
ical (Brenner, 1988) studies. In this model, calcium regu-
lates the kinetics of a step in the actomyosin ATPase path-
way. The phosphate release step was proposed as the
calcium-sensitive step (Chalovich and Eisenberg, 1982), yet
studies with caged phosphate show little change in rate with
altered calcium (Millar and Homsher, 1990; Walker et al.,
1992). The calcium sensitivity of tension redevelopment is
dramatically reduced by treatment of skinned fibers with
N-ethylmaleimide-modified S1, suggesting that the change
in kinetics is the result of strong cross-bridge activation of
the thin filament (Swartz and Moss, 1992). However, recent
skinned fiber studies using a conformationally sensitive
fluorescent probe on troponin I (Brenner et al., 1999) show
that the kinetics of troponin I fluorescence change are much
faster than tension redevelopment, and thus not limiting the
rate of tension redevelopment (Brenner and Chalovich,
1999). Thus, whether calcium regulation is via rate of
cross-bridge cycling (kinetic) or number of cycling cross-
bridges (steric) is yet to be resolved. In vitro motility studies
using regulated actin filaments show both changes in the
number of filaments moving and their speed as a function of
calcium (Homsher et al., 1996; Gordon et al., 1997), which
does not fully resolve the kinetic/steric debate on thin fila-
ment regulation.
Independent of the detailed mechanism of calcium regu-
lation, strong binding of cross-bridges plays a role in the
process. The structural and biochemical data, which do not
agree on calcium-induced movement of tropomyosin, do
agree that strong-binding cross-bridges (or S1) cause a
movement of tropomyosin. Structural studies (Popp and
Mae´da, 1993; Vibert et al., 1997) suggest that tropomyosin
is moved from near the periphery of the actin helix toward
the groove upon the binding of strong cross-bridges. The
distribution of fluorescent S1 binding in rigor myofibrils
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also supports the idea that rigor cross-bridges activate the
thin filament (Swartz et al., 1990), while calcium alone does
not fully activate the thin filament for rigor S1 binding
(Swartz et al., 1996). Biochemical data show that there is a
conformational (Ishii and Lehrer, 1990) and positional
change (Graceffa, 1999) in tropomyosin associated with
strong cross-bridge binding. A two-state model was pro-
posed by Hill et al. (1980) with calcium and/or strong
cross-bridge binding, shifting the thin filament from the
weak to strong binding state. Detailed analysis at both the
biochemical and structural level of calcium and strong
cross-bridge-induced movement of tropomyosin has led to
the proposal of three different states of the thin filament
(McKillop and Geeves, 1993; Vibert et al., 1997). The
biochemical states (McKillop and Geeves, 1993; Head et
al., 1995; Maytum et al., 1999) are defined as blocked,
closed, and open. Structurally, the three states are related to
different positions of tropomyosin at no-calcium, high-cal-
cium, and with strongly bound myosin heads (Vibert et al.,
1997). A question that remains is the contribution of
changes in troponin position to the proposed changes in
tropomyosin based upon structural studies (Lehrer, 1994;
Squire and Morris, 1998).
To test the hypothesis that strong binding cross-bridges
are involved in shifting the thin filament into the “on” or
open state, we investigated the amount and distribution of
fluorescently labeled myosin subfragment 1(fS1) in myofi-
brils with and without ADP at high and low calcium. There
are several advantages to this approach in that we use the
native thin filament, can monitor the distribution at very low
levels of fS1, and can compare the () and () ADP state
of the myosin head. Comparing () and () ADP allows
for testing whether the state of the strongly bound cross-
bridge influences the closed-to-open transition. A feature of
the McKillop and Geeves and Hill models is that the nu-
cleotide state of S1 does not influence the closed/open
(off/on) equilibrium. The current study validates our previ-
ous studies and supports the idea that strong cross-bridge
binding has a dominant role in thin filament activation,
while the nucleotide state of the strong binding cross-bridge
has little influence on the closed/open (off/on) equilibrium.
MATERIALS AND METHODS
Proteins
Myofibrils (rabbit psoas) and myosin (bovine cutaneous trunci) were
prepared as described in Swartz et al. (1990). Myosin subfragment 1 was
prepared using chymotryptic digestion, and the S1 was purified on SP-
Sephadex, as described in Swartz and Moss (1992). Fluorescent S1 (fS1)
was prepared as described in Swartz et al. (1996) with Texas Red C2
maleimide (Molecular Probes, Inc., Eugene, OR). The labeled protein was
stored as an ammonium sulfate pellet at 4°C. Before use, the protein was
desalted on a Sephadex G-25 column equilibrated with pCa 9 or 4 buffer
(see below) with 1 mM DTT.
Solutions
Calcium buffers were made by mixing stock solutions of pCa 9.0 and 3.0.
The base solution was 20 mM PIPES (pH 7.0), 4 mM MgCl2 (free), 4 mM
EGTA, 1 mM NaN3, KCl to yield 200 mM ionic strength, and CaCl2 to
yield the desired free calcium concentration. The stability constants listed
by Godt and Lindley (1982) and Fabiato’s program (1988) were used to
determine the concentrations of total MgCl2 and CaCl2 needed to achieve
the desired free ion concentrations.
Binding studies
Myofibrils (0.25 mg/ml final) were mixed with different levels of fS1
(0.1–7680 nM) in either pCa 9.0 or pCa 4.0 buffer containing 1 mM DTT
and 1 mg/ml BSA under either () or () ADP (4 mM final) conditions.
Contaminating ATP was removed from the ADP by pretreatment of stock
ADP (20 mM) with 20 mM glucose and hexokinase (10 units/ml) for 30
min. The incubation solution also contained 200 M di(adenosine) penta-
phosphate to inhibit the intrinsic myokinase activity, which could convert
ADP to ATP and AMP. Without the di(adenosine) pentaphosphate, the
myofibrils with ADP shortened independent of calcium. The myofibril/fS1
mixture was incubated for 4 h at room temperature in the dark, then 100 l
solution was spread on a coverslip and fixed with 3% formaldehyde in the
same buffer as the incubation buffer without fS1. The coverslips were
rinsed with pCa 9.0 or 4.0 buffer, then mounted on 75% glycerol, 20 mM
Tris (pH 8.5), 2 mM MgCl2, 2 mM EGTA, 1 mM NaN3, 1 mg/ml
p-phenylenediamine and sealed with nail polish. The slides were stored at
20°C until observation.
Imaging
Myofibrils were imaged using a Zeiss Axiovert TV (Thornwood, NJ)
epifluorescence microscope equipped with a 100 oil-immersion phase
contrast lens (NA 1.3), and a narrow-bandpass Texas Red filter. Digital
images were obtained with 12-bit resolution using a CCD (KAF 1300 chip,
Photometrics Inc., Tucson, AZ) controlled by a Matrox board using IPLab
Spectrum software (v3.0, Signal Analytics, Vienna, VA) run by a Macin-
tosh 840AV. The images were obtained by first acquiring the phase
contrast image and then the fluorescence image. The wide dynamic range
of fS1 levels required the use of different exposure times and a neutral
density filter in the excitation pathway to prevent saturation of the camera
at high fS1 levels. Sarcomeric fluorescence intensity data were corrected to
compensate for these variations in imaging. IPLab Spectrum software was
used for image processing and analysis of fluorescence intensity data.
Sarcomere fluorescence intensity and the fluorescence intensity ratio (non-
overlap/overlap) were measured as described in Swartz et al. (1996) with
minor modifications. The spacing from the Z-line to the non-overlap and
overlap window was 0.31 and 0.89 m, respectively, for the shorter-length
thin filaments of rabbit psoas myofibrils. Fluorescence intensity and fluo-
rescence intensity ratio data represent the mean of 18–20 myofibrils per
treatment using three contiguous, in-focus sarcomeres per myofibril. For
visual presentation, the 12-bit myofibril images were rotated to the hori-
zontal with bilinear interpolation and cropped such that a Z-line was in the
center of the image. Fluorescence images are presented in 8-bit and
individually normalized to demonstrate the fluorescent pattern, not the
fluorescence intensity.
Assays
Myofibrillar protein was determined using the biuret assay (Gornall et al.,
1949), S1 concentration using UV absorbance, and fS1 using the bicin-
choninic acid assay (Hill and Straka, 1988) with S1 as the standard. The
amount of fS1 bound to myofibrils was measured both by a biochemical
method and by image analysis using fluorescence intensity. Biochemical
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analysis was done as described in Swartz et al. (1996) using the NH4/
EDTA ATPase assay. The Pi assay of Carter and Karl (1982), with minor
modifications (Swartz et al., 1999), was used to determine ATPase activity.
Standard curves were made using fS1 to determine the free and total fS1.
Bound fS1 was determined by subtracting free activity from total activity.
Myofibrils samples without fS1 were processed in the same fashion to
correct for residual myofibrils in the supernatant. Reagents were from
Sigma Chemical Co. (St. Louis, MO) unless specified otherwise.
RESULTS
In initial studies, ADP was pretreated with glucose and
hexokinase to remove contaminating ATP. Without this
pre-treatment, the myofibrils shortened rapidly upon addi-
tion of ADP. With this treatment, acute sarcomere shorten-
ing was not observed, but a slow decrease in sarcomere
length occurred, which was inversely related to the fS1 level
(higher fS1 gave less sarcomere shortening). To eliminate
this problem, di(adenosine) pentaphosphate (a myokinase
inhibitor) was added to myofibrils before addition of ADP,
incubated for 4 h with ADP, then sarcomere length was
analyzed. This showed that, at 200–400 M di(adenosine)
pentaphosphate, the sarcomere length was essentially the
same as ()ADP controls (2.78 m, data not shown).
Lower concentrations resulted shorter sarcomere lengths
with no inhibitor, giving a sarcomere length of 2.58 m. For
all subsequent experiments, 200 M di(adenosine) penta-
phosphate was included to inhibit ATP production from
myokinase. Similar observations on the influence of ATP
contamination (both direct and indirect via myokinase) have
been noted in skinned fiber preparations (Horiuti et al.,
1997).
The amount of bound fS1 was determined biochemically
by measuring the free fS1 level in the supernatant using the
NH4/EDTA ATPase assay with fS1 as the standard. The
conditions were the same as those used for samples pre-
pared for fluorescence microscopy. Fig. 1 shows the rela-
tionship between total and bound fS1 at pCa 4 and 9 either
with or without ADP. Globally, the amount of bound fS1
saturated at fS1 levels 2.5 M. Without ADP, there was
no difference between the amount bound at high and low
calcium, while with ADP there was a difference at the
lowest fS1 level. Addition of ADP resulted in less fS1
bound at levels below 2 M, as would be expected for the
10–50-fold weaker binding of S1-ADP to actin compared to
without ADP (McKillop and Geeves, 1991). The biochem-
ical methods show that ADP influenced the amount bound,
while calcium had little influence on the amount bound with
or without ADP. This method does not give information on
the location of fS1 binding within the myofibril.
The distribution of the bound fS1 at high/low calcium
with and without ADP was observed using fluorescence
microscopy. Fig. 2 shows the distribution of fS1 at select
levels of fS1 at pCa 9 and pCa 4 without ADP to demon-
strate the differences in distribution. The distribution of fS1
at pCa 9.0 changed dramatically with increased fS1; at low
concentration (40 nM), fS1 was bound predominantly in the
overlap region and changed to the non-overlap region at
higher levels. At pCa 4.0, there was little apparent change in
distribution with increased [fS1], with the fS1 being pref-
erentially in the non-overlap region. Lower levels of fS1 at
pCa 4.0 resulted in most of the fS1 in the overlap region
(images not shown, see Fig. 5 below and Swartz et al., 1996,
Fig. 4). Fig. 3 shows the influence of ADP on fS1 distribu-
tion at pCa 9.0. The change in distribution of fS1 with
increased levels of fS1 with ADP lagged behind that with-
out ADP, but both patterns were similar at 2.5 M. At pCa
4.0, the influence of ADP was not visually apparent (images
not shown).
To determine the amount and distribution of fS1, we
measured the sarcomeric fluorescence intensity (amount)
and ratio of the intensity in the non-overlap to the overlap
region (distribution) using analytical fluorescence micros-
copy (Swartz et al., 1996, 1997). These methods reduce the
visual images into numerical data, allowing for plots of the
amount and distribution of fS1 as a function of fS1. Myo-
fibrils were incubated with a wide range of fS1 levels
(0.1–7680 nM) and imaged quantitatively using fluores-
cence microscopy. For this wide range, different exposure
times and a neutral density filter were used to ensure that the
dynamic range of the camera was not exceeded. Linearity of
the camera with exposure time using fS1-treated myofibrils
was confirmed (data not shown). The sarcomeric intensity
data were corrected for exposure conditions and plotted on
a log/log scale in Fig. 4. Globally, the sarcomeric fluores-
FIGURE 1 Fluorescent S1 binding to myofibrils measured by ATPase
activity. Myofibrils at pCa 9 (squares) or 4 (circles) and with (filled) or
without (open) ADP were incubated with different levels of fS1. Bound fS1
was removed by centrifugation and free fS1 was determined by ATPase
activity in the supernatant. Data points represent the mean  SD (n  4).
Note that there was little difference between pCa 9 and 4, while () ADP
gave less bound than without ADP at low levels of fS1.
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cence was less with ADP than without ADP, and saturated
at fS1 levels 2 M. Differences between high and low
calcium were not observed without ADP, but differences
were apparent with ADP below 2 nM fS1, with more being
bound at pCa 4.0. Comparison of the fluorescence intensity
and biochemical data show similar results in that calcium
had little influence, () ADP gave less bound than ()
ADP, and saturation at fS1 levels was 2 M.
Analysis of the distribution of fS1 is shown in Fig. 5. For
this, the fluorescence intensity was measured in a window in
the non-overlap and overlap region, and the ratio of these
was used as a measure of the distribution. A value 1 is
obtained when more fS1 is bound in the overlap region,
while a value of 2 is obtained when all available actin sites
are saturated with fS1 (Swartz et al., 1996). Globally, the
ratio saturates with a value of 1.9 at fS1 levels	2 M, as
observed for sarcomeric intensity and the biochemical as-
say. Fitting of the data with a sigmoid logistic equation of
the form intensity ratio  ((a  d)/(1  (nM fS1/c)b))  d
gave the smooth lines in the figure. The fitted values are
shown in Table 1 and relate to: a  y-intercept, b 
cooperativity parameter, c  total fS1 at the transition
FIGURE 3 The pattern of fS1 binding is influenced by ADP at pCa 9.0. Myofibrils at pCa 9.0 were incubated with different levels of fS1 without (left
two panels) or with (right two panels) 4 mM ADP, fixed, then imaged. Outer panels are phase contrast and inner panels are fluorescence images. The
fluorescence images were processed to show fluorescence pattern instead of intensity. Vertical lines note Z-lines and horizontal lines note A-bands. Note
the difference in pattern between with and without ADP at 160 and 640 nM fS1. Scale bar is 5 m.
FIGURE 2 The pattern of fS1 binding is calcium dependent. Myofibrils at pCa 9 (left two panels) or 4 (right two panels) were incubated with different
levels of fS1 (40, 160, 640, and 2560 nM) without ADP, fixed, then imaged. Outer panels are phase contrast and inner panels are fluorescence micrographs.
The fluorescence images were processed to show the fluorescence pattern instead of intensity. Vertical lines note Z-lines and horizontal lines note A-bands.
The pattern of fS1 binding was influenced by calcium and fS1 level. Scale bar is 5 m.
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midpoint, and d  peak plateau intensity ratio. At pCa 9.0,
the ratio was constant (	0.27) from 0.1 to 100 nM and there
was no difference between with and without ADP. Above
100 nM, the ratio changed substantially with small changes
in fS1 level (b  3.6 without ADP and 3.3 with ADP) and
this ratio change occurred at lower fS1 without ADP (c 
227 nM fS1) than with ADP (c  680 nM fS1). At high
calcium, the ratio was constant between 0.1 and 1 nM fS1,
then increased with increasing fS1. The ratio without ADP
ranged from 0.63 to 1.9 and was slightly higher than with
ADP (0.44 to 1.9) over most of the fS1 range. There was
little difference in the transition midpoint for high calcium
with and without ADP (18 and 24 nM fS1, respectively).
The cooperativity parameter was lower for pCa 4 (0.84 and
1.1, with and without ADP, respectively) than for pCa 9.
These data show that calcium had an influence on the
distribution of fS1 as a function of fS1 and that ADP had
little influence at high calcium and a modest influence at
low calcium.
The observation that the bound fS1 saturates at total fS1
levels 2 M (biochemical and fluorescence microscopy
analysis) allows for plotting of the ratio data as a function of
sarcomeric fluorescence intensity normalized to 7.68 M
total fS1. This presentation is shown in Fig. 6 and approx-
imates a plot of the distribution as a function of the amount
of fS1 bound and corrects for the weaker binding of S1-
ADP to the thin filament. The data with and without ADP fit
along the same line within the same calcium range. At high
calcium the data approximate a hyperbolic function, and at
low calcium the data follow a sigmoidal response. This
suggests that the changes in the intensity ratio are deter-
FIGURE 5 Fluorescence intensity ratio at high and low calcium with and
without ADP. The fluorescence intensity ratio of non-overlap/overlap was
measured as described in Materials and Methods over a wide range of fS1
levels. Data symbols are shown in the inset. The addition of ADP resulted
in the same or lower ratio as a function of fS1, and the ratio saturated at fS1
1 M at 	2.0. Data points represent the mean  SD (n  18–20
myofibrils).
FIGURE 4 Fluorescent S1 binding to myofibrils as measured by fluo-
rescence intensity. Sarcomeric fluorescence intensity was measured as
described in Material and Methods and plotted on a log/log scale against
total fS1. Data symbols are shown in the inset. There was little difference
between pCa 9 and 4 while with ADP resulted in less fS1 bound than
without ADP. Data points represent the mean  SD (n  18–20 myofi-
brils).
TABLE 1 Fitted values for sarcomeric intensity data
Condition a* b* c* d* r2†
pCa 9  ADP 0.26 3.6 227 1.93 0.99
pCa 9  ADP 0.28 3.2 680 1.90 0.99
pCa 4  ADP 0.63 1.1 24.3 1.95 0.99
pCa 4  ADP 0.44 0.84 18.6 1.88 0.99
*sarcomeric intensity  ((a  d)/(1  (nM fS1/c)b))  d. a  intensity
ratio at 0 fS1; b  cooperativity parameter; c  nM fS1 at midpoint of
transition; d  peak plateau intensity ratio.
†r2  coefficient of determination.
FIGURE 6 Fluorescence intensity ratio as a function of amount bound.
The fluorescence intensity ratio is plotted as a function of the amount of
fS1 bound (normalized sarcomeric intensity at 7.68 M fS1). Data symbols
are shown in the inset. Note that ADP has little influence on the ratio when
plotted in this manner.
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mined by the amount of strongly bound fS1 rather than the
nucleotide state of the strongly bound fS1.
DISCUSSION
Methods were developed to measure the amount and distri-
bution of strong-binding myosin heads to the regulated actin
filaments of myofibrils using quantitative digital fluores-
cence microscopy (Swartz et al., 1996). This allows for
monitoring the state of the thin filament by analysis of the
distribution of fS1 within the sarcomere. The current study
expanded the previous work by using a larger data base and
a more robust analysis. These methods were further con-
firmed by comparing sarcomeric fluorescence intensity with
biochemical measures of bound fS1. A direct correlation
between the biochemical and fluorescence intensity is not
readily doable, as the biochemical assay directly measures
the free fS1 (bound by difference) while the fluorescence
intensity directly measures bound fS1. Also, the biochemi-
cal assay had much larger errors than the intensity measure-
ments. Despite these difficulties, comparisons can be made
between the trends in the data. Both assays showed the same
trends in terms of the influence of calcium and ADP on the
amount of fS1 bound as well as saturation as a function of
total fS1 level. This suggests that the fluorescence intensity
measurements are related to the amount and distribution of fS1
rather than quenching of the fluorophore linked to the S1.
The data can be interpreted with the two-state model
developed by Hill et al. (1980) or the three-state model
developed by Geeves and colleagues (McKillop and
Geeves, 1993; Head et al., 1995; Maytum et al., 1999). Both
models postulate that calcium and strong S1 binding shift
the thin filament into the open/on state and that this transi-
tion is independent of the nucleotide bound to S1. Our
studies cannot readily support one model over the other, as
the blocked state was defined from kinetic studies (McKil-
lop and Geeves, 1993). We prefer to interpret our data from
the three-state model, as there are kinetic (Head et al., 1995)
and structural (Vibert et al., 1997) data that support this
model. The three states are blocked, closed, and open, and
the overlap and non-overlap regions of the thin filament can
be in any of these states, depending on conditions. The fS1
does not bind the blocked state and is not detected with our
methods. We assume that with or without ADP, and high or
low calcium, the overlap region is in the open state because
there are intrinsic myofibrillar cross-bridges strongly bound
to the thin filament. We also assume that the fS1 detected is
bound to actin sites in the open state rather than the closed
state. This assumption is based upon the observation that K2
(isomerization into the strong-binding open state) is 200
without ADP and 20 with ADP (Maytum et al., 1999). A
10-fold difference should result in more of the attached fS1
(both weakly and strongly bound) being in the non-overlap
region with ADP than without ADP, resulting in higher
intensity ratios for with ADP than without ADP. This was
not observed (Fig. 5).
The state of the non-overlap region is calcium- and fS1
level-dependent and can be monitored relative to the open
state in the overlap region using the fluorescence intensity
ratio. At low calcium and low fS1, the non-overlap region is
predominantly in the blocked state. At high calcium and low
fS1, the non-overlap region is predominantly in the closed
state. At saturating fS1, this region of the thin filament is in
the open state independent of calcium. By monitoring the
distribution of fS1 using the fluorescence intensity ratio as
a function of fS1 level at high and low calcium and with and
without ADP, we can further test the model within the intact
filament lattice to determine if the nucleotide state of the
strongly bound cross-bridge influences activation of the thin
filament.
The intensity ratio, in theory, should range from near 0 to
2.0 using the three-state model and the density of available
actin binding sites in the overlap and non-overlap region
(Swartz et al., 1996). Relating the intensity ratio to the
fraction of open actin sites can be done by halving the
intensity ratio. Hence, if all actins are in the open state, the
intensity ratio is 2.0 (1.0 fraction of open actin sites). Under
conditions that should result in all actins being in the open
state (primarily high fS1 levels), the curve-fitting gave a
plateau of 1.9 (0.9 fraction of open actin sites), very close to
the predicted value. The presence of the open state in the
overlap region independent of calcium or ADP is inter-
preted from the intensity data that show values 1 at low
fS1 (more fS1 in the overlap region, Fig. 5). There is a
preference for the fS1 to bind in this region because it has
the highest affinity (open state) for the fS1.
At the extreme of very low fS1, the y-intercept values
(Fig. 5) support the model in that they can be related to the
distribution of open actin sites as influenced by calcium
alone. At low calcium, the non-overlap region is primarily
in the blocked and closed state; at high calcium, the non-
overlap region is primarily in the closed state, with some
sites in the open state. This influence of calcium is shown by
the difference in the y-intercepts pCa 9 and 4 (Fig. 5). The
fraction of closed and open states is estimated at 0.22 and
0.02, respectively without calcium, while it is 0.80 and 0.20
with calcium (McKillop and Geeves, 1993). A minimum of
0.26 (0.13 fractional saturation) was obtained from curve-
fitting of the data at pCa 9.0. If fS1 was bound only to the
open sites, the intensity ratio would be 0.04 without cal-
cium. This is about sixfold lower than the observed intensity
ratio. This difference can be expected because of the nature
of light emission from a fluorophore and the spatial reso-
lution of the methods. It is assumed that the higher value is
caused by light emitted from fS1 in the overlap region. If the
region of interest for the non-overlap region were moved
closer to the Z-line, then the y-intercept value would be
lower. An alternative explanation is that attached fS1 (via
formaldehyde fixation) is bound at both open and closed
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sites. If this were the case, then the y-intercept intensity ratio
should be 0.48 [(0.22  0.02)x2]; 	2-fold higher than that
observed. While this could explain the observation, the
arguments for the fS1 detected being that bound to the open
state (described above) do not favor this, nor do the data for
pCa 4.0. If our method of measurement is not the reason for
the difference between the biochemical data and our data,
then our data at low calcium do not support the three-state
model.
The y-intercept was higher for pCa 4 than 9, supporting
the hypothesis that calcium alters the equilibrium among the
three states (McKillop and Geeves, 1993). Biochemical data
suggest that calcium alters the equilibrium among the three
states such that the closed state predominates at high cal-
cium with 80–85% of the actin being in the closed state,
and the remaining 15–20% being in the open state (Maytum
et al., 1999). Converting these proportions into intensity
ratio values give 0.3–0.4 for the open state. The y-intercept
for pCa 4 with ADP was 0.44, in strong agreement with the
biochemical data. Without ADP and at pCa 4, the intercept
was 0.63 (0.31 actin sites), which is not in strong agreement
with the biochemical data in absolute terms. In relative
terms, it is in agreement in that calcium alone does not shift
all actin sites into the open or active state because the
intensity ratio was 1. If the attached fS1 was bound to
both open and closed states, then the y-intercept would be 2
[(0.8  0.2)x2]. This was not the case, which further sup-
ports the assumption that the attached fS1 was bound to
open sites. The difference between the y-intercepts for with
and without ADP at high calcium suggests that the nucle-
otide state of fS1 may have a minor influence upon the
closed to open equilibrium. However, in this low fS1 range,
the images are difficult to analyze and the data are more
noisy.
The increases in the intensity ratio with increased fS1
were gradual at high calcium and very steep at low calcium.
Both of these changes are congruent with the three-state
model in that the binding of the fS1 shifts the actin to the
open or active state. The cooperativity parameter (steepness
of the fS1/intensity ratio relationship) determined from
curve-fitting was greater without calcium than with, which
is a feature observed in biochemical studies (Maytum et al.,
1999). However, we did not observe apparent cooperativity
at high calcium that is observed in solution (Maytum et al.,
1999). At high calcium, some of the sites (	20% in the
non-overlap region) are in the open state, and thus become
occupied with fS1 even at very low fS1 (Fig. 5). The lack of
apparent cooperativity with calcium could be because of a
difference in the native myofibrillar thin filament compared
to the reconstituted thin filament and/or our method of
measurement and analysis compared to the solution studies.
At low calcium, the transition was very steep. This is
expected because the non-overlap actin is primarily in the
blocked state. The fS1 fills the overlap actin sites first, then
binds in the non-overlap region nearest the A-band/I-band
junction and likely propagates toward the Z-line (Swartz et
al., 1990, 1996). Thus, the actin sites shift from the blocked
to closed to open state. Whether the actin can shift from the
blocked state directly to the open state cannot be addressed
with our methods.
A feature of the two- and three-state models is that the
nucleotide state of the strong binding cross-bridge does not
influence the closed (off)/open (on) transition (Hill et al.,
1980; Maytum et al., 1999). This feature has been supported
by biochemical studies (Greene, 1982; Maytum et al.,
1999). Our studies on fS1 binding to the myofibrillar thin
filament show that, at very low levels of fS1, ADP has no
influence on the distribution at low calcium and has a small
effect at high calcium, with () ADP having a greater value
for the y-intercept, suggesting a minor influence of cross-
bridge state upon the closed-to-open transition (Fig. 5).
However, when the data are plotted in relative terms to
show the change in distribution as a function of amount of
fS1 bound, there is little difference in the change in distri-
bution as a function of relative sarcomeric intensity (Fig. 6).
This plot emphasizes intermediate-to-high levels of fS1
rather than the low level fS1, as shown in Fig. 5. From the
data plotted in Fig. 6 we infer that the transition from the
closed to open state is dependent upon the number of
strongly bound cross-bridges rather than the state of the
cross-bridge in agreement with the solution binding studies.
If the nucleotide state had a significant influence on the
transition from closed to open state, then the coincidence of
the with and without ADP intensity data as a function of
relative sarcomeric intensity would not be apparent. Studies
on the geometry of the S1/actin interaction with and without
ADP suggest no difference in the position of the S1 in
skeletal muscle, while smooth muscle S1 did show a dif-
ference (Gollub et al., 1996). These observations also fit
with our observations on the influence of ADP on fS1
binding.
Other studies using mechanical measurements suggest
that ADP cross-bridges are more effective at activating actin
than nucleotide-free cross-bridges (Thirlwell et al., 1994;
Horiuti et al., 1997; Yamaguchi, 1998), which does not
agree with our interpretations on how ADP influences fS1
binding. These studies used either low MgATP to induce
calcium-free contraction (Yamaguchi, 1998) or measured-
tension transients after release of caged ATP (Thirlwell et
al., 1994; Horiuti et al., 1997). In all cases, addition of ADP
enhanced the steady-state force or amplitude of the tension
transient. This led to the conclusion that either ADP cross-
bridges are more effective activators of the thin filament
(Yamaguchi, 1998) or that ADP cross-bridges promote co-
operative activation of the thin filament, whereas nucleo-
tide-free cross-bridges do not (Thirlwell et al., 1994). Our
studies and the biochemical studies suggest that ADP does
not influence thin filament activation as measured by bind-
ing, while the mechanical studies suggest that ADP cross-
bridges are more effective activators than nucleotide-free
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cross-bridges as measured by force generation. This differ-
ence may be real in that ADP cross-bridges may be more
effective at activating force generation than binding. More
sophisticated probes for measuring thin filament activation
in myofibrils or skinned fibers are needed to address this
issue.
In conclusion, our data show that activation of the thin
filament (as measured by fS1 binding) is primarily depen-
dent upon the number of strongly bound cross-bridges and
not their nucleotide state, in agreement with the McKillop
and Geeves three-state and Hill two-state models. They also
support the concept that a major component of the activa-
tion process is the binding of strong cross-bridges to the thin
filament rather than calcium (Lehrer, 1994).
The authors thank the American Heart Association, National Affiliate
(award 9630028N) for their support.
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